Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Ecohealth|December 13, 2017
Translating Predictions of Zoonotic Viruses for PolicymakersSeth D Judson, Matthew LeBreton, Trevon Fuller, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 2019
Predictors of Viremia in Postpartum Women on Antiretroviral TherapyRisa M Hoffman, Meredith G Warshaw, K Rivet Amico, et al.
The Lancet. Global Health|April 18, 2021
Multimonth dispensing of up to 6 months of antiretroviral therapy in Malawi and Zambia (INTERVAL): a cluster-randomised, non-blinded, non-inferiority trialRisa M Hoffman, Crispin Moyo, Kelvin T Balakasi, et al.
HIV Clinical Trials|March 21, 2019
Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trialRisa M Hoffman, Konstantia Nadia Angelidou, Sean S Brummel, et al.
The Journal of Infectious Diseases|February 12, 2022
Detection and Kinetics of Subgenomic Severe Acute Respiratory Syndrome Coronavirus 2 RNA Viral Load in Longitudinal Diagnostic RNA-Positive SamplesMeagan E Deming, Tracy Q Dong, Vaidehi Agrawal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2024
Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate-Containing Antiretroviral Treatment Regimens During Pregnancy and PostpartumRisa M Hoffman, Sean Brummel, Lauren Ziemba, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 13, 2022
Self-Assessed Severity as a Determinant of Coronavirus Disease 2019 Symptom Specificity: A Longitudinal Cohort StudyAnna Bershteyn, Angela M Dahl, Tracy Q Dong, et al.
Lancet (London, England)|April 4, 2021
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trialShahin Lockman, Sean S Brummel, Lauren Ziemba, et al.
Pageof 10